Ausdal Financial Partners, Inc.
Position in TNGX — Tango Therapeutics, Inc.
CIK 1667146
Davenport, IA
Position in TNGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$281,058
New position
Shares Held
8,991
first reported quarter
Ownership
0.005%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#185
of 247 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ausdal Financial Partners, Inc. holds $2,218,484 across 8 Biotechnology names. TNGX ranks #4 (12.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
12,894 | $902,966 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
854 | $424,207 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
4,725 | $385,134 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
This page
|
8,991 | $281,058 | |
| 5 | ABCL |
AbCellera Biologics Inc.
|
15,167 | $119,060 | |
| 6 | IMRX |
Immuneering Corp
|
10,000 | $49,900 | |
| 7 | MNKD |
Mannkind Corp
|
10,507 | $44,759 | |
| 8 | ONCY |
Oncolytics Biotech Inc
|
12,000 | $11,400 |
All Filings in TNGX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $281,058 | 8,991 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||